Source: Live in Lansing MI where the nutty politicization of this issue is out of hand and there are redneck “anti-mask” protests seemingly once a month.
[1]: https://cen.acs.org/business/outsourcing/Moderna-picks-Lonza...
https://www.fiercebiotech.com/biotech/moderna-finalizes-desi...
Moderna has plans to be able to manufacturer 1 billion doses a year. AstraZeneca has announced plans to manufacturer 2 billion doses a year, with plans to produce 300 million doses by the end of 2020. The Chinese firms Sinopharm and Sinovac are ramping up their production right now, and will produce 200-300 million doses by the end of 2020. With all the other firms developing a vaccine it seems highly likely we could produce enough vaccine to vaccinate the entire population of the Earth in a single year. Now distributing and administering that much vaccine is another story, but manufacturing will not likely be the bottle neck.
Also based on the results from the study, two doses are necessary because one dose didn’t elicit a strong enough result but two did.
Then you need to administer something like 300 doses per second globally, if you have 1B doses.
This is also assuming the virus doesn’t mutate during that time (it mutates very slowly but it could still happen).
The vaccine really needs to give multi-year protection otherwise it won’t be viable in the long run.